Likewise, EGFR overexpression in breast cancer cells increases lactate production (Iqbal et al., 2021), and inhibition of EGFR tyrosine kinase signalling decreases lactate production and basal ECAR in NSCLC cells (Makinoshima et al., 2014). Here, EGFR is linked to breast cancer.